RHYTHM PHARMACEUTICALS, INC. (RYTM) Net margin 2021–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) net profit margin by fiscal year — reported net income divided by reported revenue.
-103.6%FY2025 · since FY2021: -2207.1% → -103.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -103.6% | +96.7 pp |
| FY2024 | -200.3% | +38.2 pp |
| FY2023 | -238.5% | +527.7 pp |
| FY2022 | -766.2% | +1440.9 pp |
| FY2021 | -2207.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RYTM financial trends
RYTM RevenueRYTM Net incomeRYTM Gross profitRYTM Gross marginRYTM Operating incomeRYTM Operating marginRYTM Operating cash flowRYTM Free cash flowRYTM Capital expendituresRYTM Return on equityRYTM Stock buybacksRYTM Dividends paidRYTM Total assetsRYTM Total liabilitiesRYTM Shareholders’ equityRYTM overview →